by BSMA4 | Apr 17, 2020 | BSMA Posts
The recent outbreak of the COVID-19 (Coronavirus) and the related supply chain interruptions has highlighted the vulnerability of global supply chains. Initial concern related to shutdowns in China production but as this country worked through the issues and restarted...
by BSMA4 | Apr 17, 2020 | Interview
Stefano Volonte leads North America and LatAm commercial supply chain for Roche/Genentech. During the COVID-19 pandemic, he commented on three areas: Supply chain resilience By design, Roche/Genentech had already established dual/multiple locations for several, key...
by BSMA4 | Apr 9, 2020 | BSMA Posts
A widespread awakening from the current coronavirus epidemic is how vulnerable the bio-pharmaceutical supply chain of the US is on supply from China. As the spread of COVID-19 has witnessed shortages of PPE, masks and ventilators causing loss of human lives, the issue...
by BSMA4 | Apr 9, 2020 | BSMA Posts
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While the majority of cases result in mild symptoms, some progress to pneumonia and multi-organ failure. As of March 28, 2020, the...
by BSMA4 | Apr 9, 2020 | BSMA Posts
In the wake of the Covid-19 pandemic, I and many others have witnessed our reliance on China and Asian countries for basic medical supplies (such as gowns, masks, gloves, and ventilators), leave aside many pharmaceuticals and active ingredients are made in China. This...
